0001127602-24-014115.txt : 20240503
0001127602-24-014115.hdr.sgml : 20240503
20240503160642
ACCESSION NUMBER: 0001127602-24-014115
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240502
FILED AS OF DATE: 20240503
DATE AS OF CHANGE: 20240503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Valente Nancy
CENTRAL INDEX KEY: 0001891344
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36182
FILM NUMBER: 24913051
MAIL ADDRESS:
STREET 1: C/O MYOVANT SCIENCES INC.
STREET 2: 2000 SIERRA POINT PARKWAY, 9TH FLOOR
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xencor Inc
CENTRAL INDEX KEY: 0001326732
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 201622502
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 465 N. HALSTEAD ST.
STREET 2: SUITE 200
CITY: PASADENA
STATE: CA
ZIP: 91107
BUSINESS PHONE: 626-305-5900
MAIL ADDRESS:
STREET 1: 465 N. HALSTEAD ST.
STREET 2: SUITE 200
CITY: PASADENA
STATE: CA
ZIP: 91107
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-05-02
0001326732
Xencor Inc
XNCR
0001891344
Valente Nancy
C/O XENCOR, INC.
465 N HALSTEAD STREET, SUITE 200
PASADENA
CA
91107
1
EVP, Chief Development Officer
0
Common Stock
2024-05-02
4
S
0
4745
23.5768
D
55115
D
Represents the disposition of shares that were sold to pay withholding taxes upon vesting of 13,098 restricted stock units.
/s/ Celia E. Eckert, Attorney-in-Fact
2024-05-03